102 related articles for article (PubMed ID: 13680265)
1. Screening for hemoglobin disorders in Thai pregnant women by England and Frazer's calculation method.
Suwansaksri J; Wiwanitkit V; Paritpokee N
Arch Gynecol Obstet; 2004 Dec; 270(4):211-3. PubMed ID: 13680265
[TBL] [Abstract][Full Text] [Related]
2. A cost utility analysis of the right method for screening hemoglobin E among Thai pregnant women.
Wiwanitkit V
Arch Gynecol Obstet; 2006 May; 274(2):88-90. PubMed ID: 16496168
[TBL] [Abstract][Full Text] [Related]
3. Combined one-tube osmotic fragility (OF) test and dichlorophenol-indolphenol (DCIP) test screening for hemoglobin disorders, an experience in 213 Thai pregnant women.
Wiwanitkit V; Suwansaksri J; Paritpokee N
Clin Lab; 2002; 48(9-10):525-8. PubMed ID: 12389713
[TBL] [Abstract][Full Text] [Related]
4. Screening for the carriers of thalassemias and abnormal hemoglobins at the community level.
Winichagoon P; Thitivichianlert A; Lebnak T; Piankijagum A; Fucharoen S
Southeast Asian J Trop Med Public Health; 2002; 33 Suppl 2():145-50. PubMed ID: 12755285
[TBL] [Abstract][Full Text] [Related]
5. Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women.
Sritippayawan S; Vachirasrisoontra C
J Med Assoc Thai; 2005 Apr; 88(4):449-54. PubMed ID: 16146246
[TBL] [Abstract][Full Text] [Related]
6. Hemoglobinopathy screening in pregnancy: comparison of two protocols.
Chasen ST; Loeb-Zeitlin S; Landsberger EJ
Am J Perinatol; 1999; 16(4):175-80. PubMed ID: 10458529
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of single-tube osmotic fragility as a screening test for thalassemia.
Chow J; Phelan L; Bain BJ
Am J Hematol; 2005 Jul; 79(3):198-201. PubMed ID: 15981230
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity and specificity of mean corpuscular volume testing for screening for alpha-thalassemia-1 and beta-thalassemia traits.
Sirichotiyakul S; Maneerat J; Sa-nguansermsri T; Dhananjayanonda P; Tongsong T
J Obstet Gynaecol Res; 2005 Jun; 31(3):198-201. PubMed ID: 15916654
[TBL] [Abstract][Full Text] [Related]
9. Prevention and control of thalassemia at Saraburi Regional Hospital.
Chareonkul P; Kraisin J
J Med Assoc Thai; 2004 Jan; 87(1):8-15. PubMed ID: 14971529
[TBL] [Abstract][Full Text] [Related]
10. Using of osmotic fragility (OF) and dichlorophenol-indolephenol (DCIP) tests screening for antenatal clinic: appraisal of usefulness of the program in rural Thai communities.
Wiwanitkit V
Rural Remote Health; 2006; 6(2):587. PubMed ID: 16671839
[No Abstract] [Full Text] [Related]
11. Low cost combination of DCIP and MCV was better than that of DCIP and OF in the screening for hemoglobin E.
Prayongratana K; Polprasert C; Raungrongmorakot K; Tatone K; Santiwatanakul S
J Med Assoc Thai; 2008 Oct; 91(10):1499-504. PubMed ID: 18972891
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of screening strategies for Gonorrhea among females in private sector care.
Bernstein KT; Mehta SD; Rompalo AM; Erbelding EJ
Obstet Gynecol; 2006 Apr; 107(4):813-21. PubMed ID: 16582117
[TBL] [Abstract][Full Text] [Related]
13. Screening for haemoglobinopathy--a comparison of two methods in an Irish maternity unit.
Allen NM; Ni Riain M; Murray M; Hession M; Gaffney G
Ir Med J; 2005 Oct; 98(9):276-8. PubMed ID: 16300108
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the KKU-DCIP diagnostic kit to the standard hemoglobin electrophoresis method for detection of hemoglobin E carriers.
Soogarun S; Sirimongkolsakul S; Mahakittikul B; Wiwanitkit V; Pradniwat P; Palasuwan A
Lab Hematol; 2004; 10(3):189-90. PubMed ID: 15479651
[No Abstract] [Full Text] [Related]
15. Cost-effectiveness of antenatal screening for neonatal alloimmune thrombocytopenia.
Killie MK; Kjeldsen-Kragh J; Husebekk A; Skogen B; Olsen JA; Kristiansen IS
BJOG; 2007 May; 114(5):588-95. PubMed ID: 17355359
[TBL] [Abstract][Full Text] [Related]
16. Thalassemia and hemoglobinopathies in pregnant Lao women: carrier screening, prevalence and molecular basis.
Savongsy O; Fucharoen S; Fucharoen G; Sanchaisuriya K; Sae-Ung N
Ann Hematol; 2008 Aug; 87(8):647-54. PubMed ID: 18414862
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence of hemoglobinopathies in pregnant women in the Lanzarote health sanitary area].
Calvo-Villas JM; Zapata Ramos MF; Cuesta Tovar J; de la Iglesia Iñigo S; Ropero Gradilla P; Carreter de Granda E; Sicilia Guillén F
An Med Interna; 2006 May; 23(5):206-12. PubMed ID: 16817697
[TBL] [Abstract][Full Text] [Related]
18. A simplified screening strategy for thalassaemia and haemoglobin E in rural communities in south-east Asia.
Fucharoen G; Sanchaisuriya K; Sae-ung N; Dangwibul S; Fucharoen S
Bull World Health Organ; 2004 May; 82(5):364-72. PubMed ID: 15298227
[TBL] [Abstract][Full Text] [Related]
19. Sequential and contingent prenatal screening for Down syndrome.
Wald NJ; Rudnicka AR; Bestwick JP
Prenat Diagn; 2006 Sep; 26(9):769-77. PubMed ID: 16821246
[TBL] [Abstract][Full Text] [Related]
20. First- and second-trimester evaluation of risk for Down syndrome.
Ball RH; Caughey AB; Malone FD; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Emig D; D'Alton ME;
Obstet Gynecol; 2007 Jul; 110(1):10-7. PubMed ID: 17601890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
